NCT03741491View on ClinicalTrials.gov

Birkebeiner II Study

CompletedOBSERVATIONAL
Enrollment

395

Participants

Timeline

Start Date

January 21, 2019

Primary Completion Date

November 11, 2020

Study Completion Date

July 1, 2022

Conditions
Atrial Fibrillation
Trial Locations (1)

Unknown

Diakonhjemmet Hospital, Oslo

All Listed Sponsors
collaborator

Extrastiftelsen

OTHER

lead

Diakonhjemmet Hospital

OTHER

NCT03741491 - Birkebeiner II Study | Biotech Hunter | Biotech Hunter